Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

01-Jun-19 - 29-May-20
Buy Ratio:36%


# Net Buyers:69
# Net Sellers:122

Previous 52 Weeks

02-Jun-18 - 31-May-19
Buy Ratio:34%
# Net Buyers:100
# Net Sellers:198
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Tesaro, Inc.--$3.37B  
Loxo Oncology, Inc.--$871.02M  
Eli Lilly & Co($214.48M)$393.68M  
Regeneron Pharmaceuticals, Inc.($48.61M)$341.80M  
Aimmune Therapeutics, Inc.$290.01M$298.67M  
New Net Buyers
CompanyNet Buy AmountChange
Aimmune Therapeutics, Inc.$290.01M$298.67M  
Heron Therapeutics, Inc. /de/$5.09M$113.68M  
Chemocentryx, Inc.$3.76M$97.76M  
Usana Health Sciences Inc$259.85K$97.72M  
Fate Therapeutics Inc$15.00M$32.82M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Corium International, Inc.--($297.94M)  
Precigen, Inc.$5.81M($117.26M)  
Opko Health, Inc.$2.28M($83.24M)  
Diplomat Pharmacy, Inc.($70.36M)($64.47M)  
Medicines Co /de--($53.94M)  
New Net Sellers
CompanyNet Buy AmountChange
Acceleron Pharma Inc($105.98K)($25.87M)  
Galectin Therapeutics Inc($58.54K)($10.91M)  
Amicus Therapeutics, Inc.($3.74M)($6.45M)  
Bausch Health Companies Inc.($548.92K)($5.66M)  
Epizyme, Inc.($1.35M)($5.31M)